-
1
-
-
0033581097
-
Cancer surveillance series: Brain and other central nervous system cancers: Recent trends in incidence and mortality
-
doi: 10.1093/jnci/91.16.1382
-
Legler JM, Ries LA, Smith MA, Warren JL, Heineman EF, Kaplan RS, et al. Cancer surveillance series: brain and other central nervous system cancers: recent trends in incidence and mortality. J Natl Cancer Inst. 1999;91:1382-90, doi: 10.1093/jnci/91.16.1382.
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 1382-1390
-
-
Legler, J.M.1
Ries, L.A.2
Smith, M.A.3
Warren, J.L.4
Heineman, E.F.5
Kaplan, R.S.6
-
2
-
-
0035843243
-
Brain tumors
-
doi: 10. 1056/NEJM200101113440207
-
DeAngelis LM. Brain tumors. N Engl J Med. 2001;344:114-23, doi: 10. 1056/NEJM200101113440207
-
(2001)
N Engl J Med
, vol.344
, pp. 114-123
-
-
Deangelis, L.M.1
-
3
-
-
0036787611
-
Epidemiology of primary brain tumors: Current concepts and review of the literature
-
Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002;4:278-9.
-
(2002)
Neuro Oncol
, vol.4
, pp. 278-279
-
-
Wrensch, M.1
Minn, Y.2
Chew, T.3
Bondy, M.4
Berger, M.S.5
-
4
-
-
35949002429
-
Malignant astrocytic glioma: Genetics, biology, and paths to treatment
-
doi: 10.1101/gad.1596707
-
Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683-710, doi: 10.1101/gad.1596707.
-
(2007)
Genes Dev
, vol.21
, pp. 2683-2710
-
-
Furnari, F.B.1
Fenton, T.2
Bachoo, R.M.3
Mukasa, A.4
Stommel, J.M.5
Stegh, A.6
-
5
-
-
34547122001
-
The 2007 WHO classification of tumours of the central nervous system
-
doi: 10.1007/s00401-007-0243-4
-
Loius DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109, doi: 10.1007/s00401-007-0243-4.
-
(2007)
Acta Neuropathol
, vol.114
, pp. 97-109
-
-
Loius, D.N.1
Ohgaki, H.2
Wiestler, O.D.3
Cavenee, W.K.4
Burger, P.C.5
Jouvet, A.6
-
6
-
-
67650874081
-
Cancer statistics, 2009
-
doi: 10.3322/caac.20006
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49, doi: 10.3322/caac.20006.
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
7
-
-
77349117235
-
Survival comparison between glioblastoma multiforme and other incurable cancers
-
doi: 10.1016/j.jocn.2009.09.004
-
Tran B, Rosenthal MA. Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci. 2010;17:417-21, doi: 10.1016/j.jocn.2009.09.004.
-
(2010)
J Clin Neurosci
, vol.17
, pp. 417-421
-
-
Tran, B.1
Rosenthal, M.A.2
-
8
-
-
78650271417
-
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
-
Bauchet L, Mathieu-Daude H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O, et al. Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. Neuro-oncol. 2010;12:725-35.
-
(2010)
Neuro-oncol
, vol.12
, pp. 725-735
-
-
Bauchet, L.1
Mathieu-Daude, H.2
Fabbro-Peray, P.3
Rigau, V.4
Fabbro, M.5
Chinot, O.6
-
9
-
-
79851502267
-
Gliomas in adults
-
Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R. Gliomas in adults. Dtsch Arztebl Int. 2010;107:799-807.
-
(2010)
Dtsch Arztebl Int
, vol.107
, pp. 799-807
-
-
Schneider, T.1
Mawrin, C.2
Scherlach, C.3
Skalej, M.4
Firsching, R.5
-
10
-
-
0018125603
-
EvaluationofBCNU and/or radiotherapyinthe treatment of anaplastic gliomas. A cooperative trial
-
Walker MD, Alexander Jr E, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. EvaluationofBCNU and/or radiotherapyinthe treatment of anaplastic gliomas. A cooperative trial. J Neurosurg.1978;49:333-43.
-
(1978)
J Neurosurg
, vol.49
, pp. 333-343
-
-
Walker, M.D.1
Alexander, E.2
Hunt, W.E.3
Maccarty, C.S.4
Mahaley, M.S.5
Mealey, J.6
-
11
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
doi: 10.1056/ NEJMoa043330
-
Stupp R, Mason W, Van den Bert MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-96, doi: 10.1056/ NEJMoa043330.
-
(2005)
N Engl J Med
, vol.352
, pp. 987-996
-
-
Stupp, R.1
Mason, W.2
van den Bert, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.6
-
12
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
doi: 10.1126/science.1164382
-
Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807-12, doi: 10.1126/science.1164382.
-
(2008)
Science
, vol.321
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
Lin, J.C.4
Leary, R.J.5
Angenendt, P.6
-
13
-
-
79251629946
-
The genetic landscape of the childhood cancer medulloblastoma
-
doi: 10.1126/science.1198056
-
Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, et al. The genetic landscape of the childhood cancer medulloblastoma. Science. 2011;331:435-9, doi: 10.1126/science.1198056.
-
(2011)
Science
, vol.331
, pp. 435-439
-
-
Parsons, D.W.1
Li, M.2
Zhang, X.3
Jones, S.4
Leary, R.J.5
Lin, J.C.6
-
14
-
-
0025312728
-
A genetic model for colorectal tumorigenesis
-
doi: 10.1016/0092-8674(90)90186-I
-
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61:759-67, doi: 10.1016/0092-8674(90)90186-I.
-
(1990)
Cell
, vol.61
, pp. 759-767
-
-
Fearon, E.R.1
Vogelstein, B.2
-
15
-
-
54549108740
-
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
-
The Cancer Genome Atlas Research Network, doi: 10.1038/nature07385
-
The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-8, doi: 10.1038/nature07385.
-
(2008)
Nature
, vol.455
, pp. 1061-1068
-
-
-
16
-
-
58149389573
-
Association of EGFR c.2073A.T polymorphism with decreased risk of diffusely infiltrating astrocytoma in a Brazilian case- control study
-
Barbosa KC, Oba-Shinjo SM, Uno M, Carvalho PO, Rosemberg S, Aguiar PH, et al. Association of EGFR c.2073A.T polymorphism with decreased risk of diffusely infiltrating astrocytoma in a Brazilian case- control study. Int J Biol Markers. 2008;23:140-6.
-
(2008)
Int J Biol Markers
, vol.23
, pp. 140-146
-
-
Barbosa, K.C.1
Oba-Shinjo, S.M.2
Uno, M.3
Carvalho, P.O.4
Rosemberg, S.5
Aguiar, P.H.6
-
17
-
-
67349114519
-
ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas
-
doi: 10.1007/s10238-009-0040-6
-
Burim RV, Teixeira SA, Colli BO, Peria FM, Tirapelli LF, Marie SK, et al. ICAM-1 (Lys469Glu) and PECAM-1 (Leu125Val) polymorphisms in diffuse astrocytomas. Clin Exp Med. 2009;9:157-63, doi: 10.1007/s10238-009-0040-6.
-
(2009)
Clin Exp Med
, vol.9
, pp. 157-163
-
-
Burim, R.V.1
Teixeira, S.A.2
Colli, B.O.3
Peria, F.M.4
Tirapelli, L.F.5
Marie, S.K.6
-
18
-
-
63749125730
-
Translating biology into clinics: The case of glioblastoma
-
doi: 10.1016/j.ceb. 2008.12.009
-
Lino M, Merlo A. Translating biology into clinics: the case of glioblastoma. Curr Opin Cell Biol. 2009;21:311-16, doi: 10.1016/j.ceb. 2008.12.009.
-
(2009)
Curr Opin Cell Biol
, vol.21
, pp. 311-316
-
-
Lino, M.1
Merlo, A.2
-
19
-
-
78650117285
-
Genetic and molecular abnormalities of glioblastomas (GBM)
-
Larsen C. Genetic and molecular abnormalities of glioblastomas (GBM). Bull Cancer. 2010;97:1389-407.
-
(2010)
Bull Cancer
, vol.97
, pp. 1389-1407
-
-
Larsen, C.1
-
20
-
-
1942469956
-
MGMT: Its role in cancer aetiology and cancer therapeutics
-
doi: 10.1038/nrc1319
-
Gerson SL. MGMT: its role in cancer aetiology and cancer therapeutics. Nature Rev Cancer. 2004;4:296-307, doi: 10.1038/nrc1319.
-
(2004)
Nature Rev Cancer
, vol.4
, pp. 296-307
-
-
Gerson, S.L.1
-
21
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
doi: 10.1056/ NEJMoa043331
-
Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997-1003, doi: 10.1056/ NEJMoa043331.
-
(2005)
N Engl J Med
, vol.352
, pp. 997-1003
-
-
Hegi, M.E.1
Diserens, A.C.2
Gorlia, T.3
Hamou, M.F.4
de Tribolet, N.5
Weller, M.6
-
22
-
-
75149166496
-
MGMT promoter methylation in malignant gliomas: Ready for personalized medicine?
-
Weller M, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W, Hegi ME. MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol. 2010;6:39-51.
-
(2010)
Nat Rev Neurol
, vol.6
, pp. 39-51
-
-
Weller, M.1
Stupp, R.2
Reifenberger, G.3
Brandes, A.A.4
van den Bent, M.J.5
Wick, W.6
Hegi, M.E.7
-
23
-
-
0000459772
-
Der Tumoren de Stoffwechsel do den de Ueber
-
Warburg O, Posener K, Negelein E. Der Tumoren de Stoffwechsel do den de Ueber. Biochem Z. 1924;152:319-44.
-
(1924)
Biochem Z
, vol.152
, pp. 319-344
-
-
Warburg, O.1
Posener, K.2
Negelein, E.3
-
24
-
-
12444279265
-
On the origin of cancer cells
-
doi: 10.1126/science.123.3191.309
-
Warburg O. On the origin of cancer cells. Science. 1956;123:309-14, doi: 10.1126/science.123.3191.309.
-
(1956)
Science
, vol.123
, pp. 309-314
-
-
Warburg, O.1
-
25
-
-
77949967131
-
Targeting metabolic transformation for cancer therapy
-
doi: 10.1038/ nrc2817
-
Tennant DA, Durán RV, Gottlieb E. Targeting metabolic transformation for cancer therapy. Nature Rev Cancer. 2010;10:267-77, doi: 10.1038/ nrc2817.
-
(2010)
Nature Rev Cancer
, vol.10
, pp. 267-277
-
-
Tennant, D.A.1
Durán, R.V.2
Gottlieb, E.3
-
26
-
-
0034940164
-
Dietary regulation of expression of glucose-6-phosphate dehydrogenase
-
doi: 10.1146/annurev.nutr.21.1.121
-
Saiati LM, Amir-Ahmady B. Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu Rev Nutr. 2001;21:121-40, doi: 10.1146/annurev.nutr.21.1.121.
-
(2001)
Annu Rev Nutr
, vol.21
, pp. 121-140
-
-
Saiati, L.M.1
Amir-Ahmady, B.2
-
27
-
-
67650165225
-
Metabolic transformation in cancer
-
doi: 10.1093/carcin/ bgp070
-
Tennant DA, Duran RV, Boulahbel H, Gottieb E. Metabolic transformation in cancer. Carcinogenesis. 2009;30:1269-80, doi: 10.1093/carcin/ bgp070.
-
(2009)
Carcinogenesis
, vol.30
, pp. 1269-1280
-
-
Tennant, D.A.1
Duran, R.V.2
Boulahbel, H.3
Gottieb, E.4
-
28
-
-
33644614520
-
HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia
-
doi: 10.1016/j.cmet.2006.02.002
-
Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3:177-85, doi: 10.1016/j.cmet.2006.02.002.
-
(2006)
Cell Metab
, vol.3
, pp. 177-185
-
-
Kim, J.W.1
Tchernyshyov, I.2
Semenza, G.L.3
Dang, C.V.4
-
29
-
-
0033079597
-
Oncogenic alteration of metabolism
-
doi: 10.1016/S0968-0004(98)01344-9
-
Dang CV, Semenza GI. Oncogenic alteration of metabolism. Trends Biochem Sci. 1999;24:68-72, doi: 10.1016/S0968-0004(98)01344-9.
-
(1999)
Trends Biochem Sci
, vol.24
, pp. 68-72
-
-
Dang, C.V.1
Semenza, G.I.2
-
30
-
-
33744783432
-
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
-
doi: 10.1016/j.ccr.2006. 04.023
-
Fantin VR, St-Pierre J, Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 2006;9:425-34, doi: 10.1016/j.ccr.2006. 04.023.
-
(2006)
Cancer Cell
, vol.9
, pp. 425-434
-
-
Fantin, V.R.1
St-Pierre, J.2
Leder, P.3
-
31
-
-
76649126249
-
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
-
doi: 10.1073/pnas.0914433107
-
Le A, Cooper CR, Gouw AM, Dinavahi R, Maitra A, Deck LM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci USA. 2010;107:2037-42, doi: 10.1073/pnas.0914433107.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 2037-2042
-
-
Le, A.1
Cooper, C.R.2
Gouw, A.M.3
Dinavahi, R.4
Maitra, A.5
Deck, L.M.6
-
32
-
-
61849135453
-
Tumor suppressors and cell metabolism: A recipe for cancer growth
-
doi: 10.1101/gad. 1756509
-
Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev. 2009;23:537-48, doi: 10.1101/gad. 1756509.
-
(2009)
Genes Dev
, vol.23
, pp. 537-548
-
-
Jones, R.G.1
Thompson, C.B.2
-
33
-
-
53049087909
-
Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells
-
doi: 10.1074/jbc.M801765200
-
McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, Halim ND, et al. Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem. 2008;283:22700-8, doi: 10.1074/jbc.M801765200.
-
(2008)
J Biol Chem
, vol.283
, pp. 22700-22708
-
-
McFate, T.1
Mohyeldin, A.2
Lu, H.3
Thakar, J.4
Henriques, J.5
Halim, N.D.6
-
34
-
-
74849137483
-
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo
-
doi: 10.1007/s10549-009-0435-9
-
Sun RC, Fadia M, Dahlstrom JE, Parish CR, Board PG, Blackburn AC. Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat. 2009;120:253-60, doi: 10.1007/s10549-009-0435-9.
-
(2009)
Breast Cancer Res Treat
, vol.120
, pp. 253-260
-
-
Sun, R.C.1
Fadia, M.2
Dahlstrom, J.E.3
Parish, C.R.4
Board, P.G.5
Blackburn, A.C.6
-
35
-
-
33744942376
-
Acid-mediated tumor invasion: A multidisciplinary study
-
doi: 10.1158/0008-5472.CAN-05-4193
-
Gatenby RA, Gawlinski ET, Gmitro AF, Kaylor B, Gillies RJ. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res. 2006;66:5216-23, doi: 10.1158/0008-5472.CAN-05-4193.
-
(2006)
Cancer Res
, vol.66
, pp. 5216-5223
-
-
Gatenby, R.A.1
Gawlinski, E.T.2
Gmitro, A.F.3
Kaylor, B.4
Gillies, R.J.5
-
36
-
-
23044500915
-
Pyruvate kinase type M2 and its role in tumor growth and spreading
-
doi: 10.1016/j.semcancer.2005.04.009
-
Mazurek S, Boschel CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005;15:300-8, doi: 10.1016/j.semcancer.2005.04.009.
-
(2005)
Semin Cancer Biol
, vol.15
, pp. 300-308
-
-
Mazurek, S.1
Boschel, C.B.2
Hugo, F.3
Eigenbrodt, E.4
-
37
-
-
40749163248
-
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
-
doi: 10.1038/nature06734
-
Christofk HR, Vander Heiden MG, Harris MH, Ramanathan A, Gerszten RE, Wei R, et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature. 2008;452:230-3, doi: 10.1038/nature06734.
-
(2008)
Nature
, vol.452
, pp. 230-233
-
-
Christofk, H.R.1
van der Heiden, M.G.2
Harris, M.H.3
Ramanathan, A.4
Gerszten, R.E.5
Wei, R.6
-
38
-
-
0036172228
-
Pyruvate kinase type M2: A crossroad in the tumor metabolome
-
doi: 10.1079/BJN2001454
-
Mazurek S, Grimm H, Boschek CB, Vaupel P, Eigenbrodt E. Pyruvate kinase type M2: a crossroad in the tumor metabolome. Br J Nutr. 2002;87:S23-9, doi: 10.1079/BJN2001454.
-
(2002)
Br J Nutr
, vol.87
-
-
Mazurek, S.1
Grimm, H.2
Boschek, C.B.3
Vaupel, P.4
Eigenbrodt, E.5
-
39
-
-
40749099894
-
Pyruvate kinase M2 is a phosphotyrosine-binding protein
-
doi: 10.1038/nature06667
-
Christofk HR, Vander Heiden MG, Wu N, Asara JM, Cantley LC. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature. 2008;452:181-6, doi: 10.1038/nature06667.
-
(2008)
Nature
, vol.452
, pp. 181-186
-
-
Christofk, H.R.1
Vander Heiden, M.G.2
Wu, N.3
Asara, J.M.4
Cantley, L.C.5
-
40
-
-
0026467983
-
Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells
-
Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H, Friis R. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. Crit Rev Oncog. 1992,3:91-115.
-
(1992)
Crit Rev Oncog
, vol.3
, pp. 91-115
-
-
Eigenbrodt, E.1
Reinacher, M.2
Scheefers-Borchel, U.3
Scheefers, H.4
Friis, R.5
-
41
-
-
0030748651
-
Phosphorylation and activation of heart 6-phosphofructo-2-kinase bt protein kinase B and other protein kinases of the insulin signaling cascades
-
doi: 10.1074/jbc.272.28.17269
-
Deprez J, Vertommen D, Alessi DR, Hue L, Rider MH. Phosphorylation and activation of heart 6-phosphofructo-2-kinase bt protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem. 1997;272:17269-75, doi: 10.1074/jbc.272.28.17269.
-
(1997)
J Biol Chem
, vol.272
, pp. 17269-17275
-
-
Deprez, J.1
Vertommen, D.2
Alessi, D.R.3
Hue, L.4
Rider, M.H.5
-
42
-
-
38349183620
-
Small-molecule inhibition of 6-phosphofructo2-kinase activity suppresses glycolytic flux and tumor growth
-
doi: 10.1158/1535-7163.MCT-07-0482
-
Clem B, Telang S, Clem A, Yalcin A, Meier J, Simmons A, et al. Small-molecule inhibition of 6-phosphofructo2-kinase activity suppresses glycolytic flux and tumor growth. Mol Cancer Ther. 2008;7:110-20, doi: 10.1158/1535-7163.MCT-07-0482.
-
(2008)
Mol Cancer Ther
, vol.7
, pp. 110-120
-
-
Clem, B.1
Telang, S.2
Clem, A.3
Yalcin, A.4
Meier, J.5
Simmons, A.6
-
43
-
-
33746924468
-
Hexokinase II: Cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria
-
doi: 10.1038/ sj.onc.1209603
-
Mathupala SP, Ko YH, Pedersen PL. Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene. 2006;25:4777-86, doi: 10.1038/ sj.onc.1209603.
-
(2006)
Oncogene
, vol.25
, pp. 4777-4786
-
-
Mathupala, S.P.1
Ko, Y.H.2
Pedersen, P.L.3
-
44
-
-
0842345400
-
VDAC: The channel at the interface between mitochondria and the cytosol
-
doi: 10.1023/ B:MCBI.0000009862.17396.8d
-
Colombini M. VDAC: the channel at the interface between mitochondria and the cytosol. Mol Cell Biochem. 2004;256-7:107-15, doi: 10.1023/ B:MCBI.0000009862.17396.8d.
-
(2004)
Mol Cell Biochem
, vol.256
, pp. 107-115
-
-
Colombini, M.1
-
45
-
-
0038206442
-
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme
-
doi: 10. 1023/A:1023756707900
-
Oudard S, Carpentier A, Banu E, Fauchon F, Celerier D, Poupon MF, et al. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol. 2003;63:81-6, doi: 10. 1023/A:1023756707900.
-
(2003)
J Neurooncol
, vol.63
, pp. 81-86
-
-
Oudard, S.1
Carpentier, A.2
Banu, E.3
Fauchon, F.4
Celerier, D.5
Poupon, M.F.6
-
46
-
-
41549113465
-
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor
-
doi: 10.1158/1078-0432.CCR-07-1607
-
Cao X, Bloomston M, Zhang T, Frankel WL, Jia G, Wang B, et al. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor. Clin Cancer Res. 2008;14:1831-9, doi: 10.1158/1078-0432.CCR-07-1607.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 1831-1839
-
-
Cao, X.1
Bloomston, M.2
Zhang, T.3
Frankel, W.L.4
Jia, G.5
Wang, B.6
-
47
-
-
4744341871
-
Advanced cancers: Eradication in all cases using 3-bromopyruvate therapy to deplete ATP
-
doi: 10.1016/j.bbrc.2004.09.047
-
Ko YH, Smith BL, Wang Y, Pomper MG, Rini DA, Torbenson MS, et al. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. Biochem Biophys Res Commun. 2004;324:269-75, doi: 10.1016/j.bbrc.2004.09.047.
-
(2004)
Biochem Biophys Res Commun
, vol.324
, pp. 269-275
-
-
Ko, Y.H.1
Smith, B.L.2
Wang, Y.3
Pomper, M.G.4
Rini, D.A.5
Torbenson, M.S.6
-
48
-
-
37449024702
-
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
-
doi: 10.1016/j.cmet.2007.10.002
-
DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11-20, doi: 10.1016/j.cmet.2007.10.002.
-
(2008)
Cell Metab
, vol.7
, pp. 11-20
-
-
Deberardinis, R.J.1
Lum, J.J.2
Hatzivassiliou, G.3
Thompson, C.B.4
-
49
-
-
34648828532
-
AMP-activated/SNF1 protein kinases: Conserved guardians of cellular energy
-
doi: 10. 1038/nrm2249
-
Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nature Rev Mol Cell Biol. 2007;8:774-85, doi: 10. 1038/nrm2249.
-
(2007)
Nature Rev Mol Cell Biol
, vol.8
, pp. 774-785
-
-
Hardie, D.G.1
-
50
-
-
37449034854
-
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
-
doi: 10.1073/pnas.0709747104
-
DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, et al. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104:19345-50, doi: 10.1073/pnas.0709747104.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 19345-19350
-
-
Deberardinis, R.J.1
Mancuso, A.2
Daikhin, E.3
Nissim, I.4
Yudkoff, M.5
Wehrli, S.6
-
51
-
-
75149148563
-
Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer
-
doi: 10.1038/onc.2009.358
-
DeBerardinis RJ, Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 2009;29:313-24, doi: 10.1038/onc.2009.358.
-
(2009)
Oncogene
, vol.29
, pp. 313-324
-
-
Deberardinis, R.J.1
Cheng, T.2
-
52
-
-
0028210550
-
Selective activity of phenylacetate against malignant gliomas: Resemblance to fetal brain damage in phenylketonuria
-
Samid D, Ram Z, Hudgins WR, Shack S, Liu L, Walbridge S, et al. Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria. Cancer Res. 1994;54:891-5.
-
(1994)
Cancer Res
, vol.54
, pp. 891-895
-
-
Samid, D.1
Ram, Z.2
Hudgins, W.R.3
Shack, S.4
Liu, L.5
Walbridge, S.6
-
53
-
-
0019461053
-
Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase
-
Rosenfeld H, Roberts J. Enhancement of antitumor activity of glutamine antagonists 6-diazo-5-oxo-L-norleucine and acivicin in cell culture by glutaminase-asparaginase. Cancer Res. 1981;41:1324-8.
-
(1981)
Cancer Res
, vol.41
, pp. 1324-1328
-
-
Rosenfeld, H.1
Roberts, J.2
-
54
-
-
26644441651
-
ATP citrate lyase inhibition can suppress tumor cell growth
-
doi: 10.1016/j.ccr.2005.09.008
-
Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell. 2005;8:311-21, doi: 10.1016/j.ccr.2005.09.008.
-
(2005)
Cancer Cell
, vol.8
, pp. 311-321
-
-
Hatzivassiliou, G.1
Zhao, F.2
Bauer, D.E.3
Andreadis, C.4
Shaw, A.N.5
Dhanak, D.6
-
55
-
-
0035866378
-
Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53
-
Li JN, Gorospe M, Chrest FJ, Kumaravel TS, Evans MK, Han WF, et al. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res. 2001;61:1493-9.
-
(2001)
Cancer Res
, vol.61
, pp. 1493-1499
-
-
Li, J.N.1
Gorospe, M.2
Chrest, F.J.3
Kumaravel, T.S.4
Evans, M.K.5
Han, W.F.6
-
56
-
-
52649107626
-
Cancer cell metabolism: Warburg and beyond
-
doi: 10.1016/j.cell.2008.08.021
-
Hau PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703-7, doi: 10.1016/j.cell.2008.08.021.
-
(2008)
Cell
, vol.134
, pp. 703-707
-
-
Hau, P.P.1
Sabatini, D.M.2
-
57
-
-
60949111125
-
C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase I and decreases food intake and body weight
-
doi: 10. 1016/j.bcp.2008.11.020
-
Mera P, Bentebibel A, López-Viñas E, Cordente AG, Gurunathan C, Sebastián D, et al. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase I and decreases food intake and body weight. Biochem Pharmacol. 2009;77:1084-95, doi: 10. 1016/j.bcp.2008.11.020.
-
(2009)
Biochem Pharmacol
, vol.77
, pp. 1084-1095
-
-
Mera, P.1
Bentebibel, A.2
López-Viñas, E.3
Cordente, A.G.4
Gurunathan, C.5
Sebastián, D.6
-
58
-
-
28544446058
-
Mitochondrial tumor suppressors: A genetic and biochemical update
-
doi: 10. 1038/nrc1737
-
Gottlieb E, Tomlinson IP. Mitochondrial tumor suppressors: a genetic and biochemical update. Nature Rev Cancer. 2005;5:857-66, doi: 10. 1038/nrc1737.
-
(2005)
Nature Rev Cancer
, vol.5
, pp. 857-866
-
-
Gottlieb, E.1
Tomlinson, I.P.2
-
59
-
-
54949098894
-
Nucleotide analog: Molecular mechanisms signaling cell death
-
doi: 10. 1038/onc.2008.316
-
Ewald B, Sampath D, Plunkett W. Nucleotide analog: molecular mechanisms signaling cell death. Oncogene. 2008;27:6522-37, doi: 10. 1038/onc.2008.316.
-
(2008)
Oncogene
, vol.27
, pp. 6522-6537
-
-
Ewald, B.1
Sampath, D.2
Plunkett, W.3
-
60
-
-
21244460340
-
Mutations in the transketolase-like gene TKTL1: Clinical implications for neurodegenerative diseases, diabetes and cancer
-
Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab. 2005;51:257-73.
-
(2005)
Clin Lab
, vol.51
, pp. 257-273
-
-
Coy, J.F.1
Dressler, D.2
Wilde, J.3
Schubert, P.4
-
61
-
-
60549110886
-
Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells
-
doi: 10.1002/ijc.24078
-
Xu X, Zur Hausen A, Coy JF, Lochelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer. 2009;124:1330-7, doi: 10.1002/ijc.24078.
-
(2009)
Int J Cancer
, vol.124
, pp. 1330-1337
-
-
Xu, X.1
Zur Hausen, A.2
Coy, J.F.3
Lochelt, M.4
-
62
-
-
33846910173
-
Global reconstruction of the human metabolic network based on genomic and bibliomic data
-
doi: 10.1073/pnas.0610772104
-
Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, Vo TD, et al. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA. 2007;104:1777-82, doi: 10.1073/pnas.0610772104.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 1777-1782
-
-
Duarte, N.C.1
Becker, S.A.2
Jamshidi, N.3
Thiele, I.4
Mo, M.L.5
Vo, T.D.6
-
63
-
-
79952971590
-
IDH1 mutations in a Brazilian series of glioblastoma
-
doi: 10.1590/S1807-59322011000100028
-
Uno M, Oba-Shinjo SM, Silva R, Miura F, Clara CA, Almeida JRW, et al. IDH1 mutations in a Brazilian series of glioblastoma. Clinics. 2011;66:163-5, doi: 10.1590/S1807-59322011000100028.
-
(2011)
Clinics
, vol.66
, pp. 163-165
-
-
Uno, M.1
Oba-Shinjo, S.M.2
Silva, R.3
Miura, F.4
Clara, C.A.5
Almeida, J.R.W.6
-
64
-
-
58349111311
-
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors
-
doi: 10.1002/humu.20937
-
Bleeker FE, Lamba S, Leenstra S, Troost D, Hulsebos T, Vandertop WP, et al. IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum Mutat. 2009;30:7-11, doi: 10.1002/humu.20937.
-
(2009)
Hum Mutat
, vol.30
, pp. 7-11
-
-
Bleeker, F.E.1
Lamba, S.2
Leenstra, S.3
Troost, D.4
Hulsebos, T.5
Vandertop, W.P.6
-
65
-
-
60849115270
-
IDH1 and IDH2 mutations in gliomas
-
doi: 10.1056/NEJMoa0808710
-
Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765-73, doi: 10.1056/NEJMoa0808710.
-
(2009)
N Engl J Med
, vol.360
, pp. 765-773
-
-
Yan, H.1
Parsons, D.W.2
Jin, G.3
McLendon, R.4
Rasheed, B.A.5
Yuan, W.6
-
66
-
-
0032741434
-
The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase
-
doi: 10.1074/jbc.274.43.30527
-
Geisbretcht BV, Gould SJ. The human PICD gene encodes a cytoplasmic and peroxisomal NADP(+)-dependent isocitrate dehydrogenase. J Biol Chem. 1999;274:30527-33, doi: 10.1074/jbc.274.43.30527.
-
(1999)
J Biol Chem
, vol.274
, pp. 30527-30533
-
-
Geisbretcht, B.V.1
Gould, S.J.2
-
67
-
-
0034867911
-
Localization of cytosolic NADP-dependent isocitrate dehydrogenase in the peroxisomes of rat liver cells: Biochemical and immunocytochemical studies
-
doi: 10.1177/ 002215540104900906
-
Yoshihara T, Hamamoto T, Munakata R, Tajiri R, Ohsumi M, Yokota S. Localization of cytosolic NADP-dependent isocitrate dehydrogenase in the peroxisomes of rat liver cells: biochemical and immunocytochemical studies. J Histochem Cytochem. 2001;49:1123-31, doi: 10.1177/ 002215540104900906.
-
(2001)
J Histochem Cytochem
, vol.49
, pp. 1123-1131
-
-
Yoshihara, T.1
Hamamoto, T.2
Munakata, R.3
Tajiri, R.4
Ohsumi, M.5
Yokota, S.6
-
68
-
-
0023033372
-
Multiple NADPH-producing pathways control glutathione (GSH) content in retina
-
doi: 10.1016/S0014-4835(86)80013-6
-
Winkler BS, DeSantis N, Solomon F. Multiple NADPH-producing pathways control glutathione (GSH) content in retina. Exp Eye Res. 1986;4:829-47, doi: 10.1016/S0014-4835(86)80013-6.
-
(1986)
Exp Eye Res
, vol.4
, pp. 829-847
-
-
Winkler, B.S.1
Desantis, N.2
Solomon, F.3
-
69
-
-
0027310324
-
Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenase
-
Haselbeck RJ, McAlister-Henn L. Function and expression of yeast mitochondrial NAD- and NADP-specific isocitrate dehydrogenase. J Biol Chem. 1993;268:12116-22.
-
(1993)
J Biol Chem
, vol.268
, pp. 12116-12122
-
-
Haselbeck, R.J.1
McAlister-Henn, L.2
-
70
-
-
77954697566
-
Isocitrate dehydrogenase 1 and 2 mutations in cancer: Alterations at a crossroad of cellular metabolism
-
doi: 10.1093/jnci/djq187
-
Reitman ZJ, Yan H. Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroad of cellular metabolism. J Natl Cancer Inst. 2010;102:932-41, doi: 10.1093/jnci/djq187.
-
(2010)
J Natl Cancer Inst
, vol.102
, pp. 932-941
-
-
Reitman, Z.J.1
Yan, H.2
-
71
-
-
60849139085
-
Metabolic enzymes as oncogenes or tumor suppressors
-
doi: 10.1056/NEJMe0810213
-
Thompson CB. Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med. 2009;360:813-15, doi: 10.1056/NEJMe0810213.
-
(2009)
N Engl J Med
, vol.360
, pp. 813-815
-
-
Thompson, C.B.1
-
72
-
-
77953019788
-
The prognostic IDH1 (R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
-
doi: 10.1007/s00401-010-0645-6
-
Bleeker FE, Atai NA, Lamba S, Jonker A, Rijkeboer D, Bosch KS, et al. The prognostic IDH1 (R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma. Acta Neuropatholol. 2010;119:487-94, doi: 10.1007/s00401-010-0645-6.
-
(2010)
Acta Neuropatholol
, vol.119
, pp. 487-494
-
-
Bleeker, F.E.1
Atai, N.A.2
Lamba, S.3
Jonker, A.4
Rijkeboer, D.5
Bosch, K.S.6
-
73
-
-
64849098267
-
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha
-
doi: 10.1126/science. 1170944
-
Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science. 2009;324:261-5, doi: 10.1126/science. 1170944.
-
(2009)
Science
, vol.324
, pp. 261-265
-
-
Zhao, S.1
Lin, Y.2
Xu, W.3
Jiang, W.4
Zha, Z.5
Wang, P.6
-
74
-
-
77955508065
-
Glioma-derived mutations in IDH: From mechanism to potential therapy
-
doi: 10.1016/j.bbrc.2010.05.115
-
Fu Y, Huang R, Du J, Yang R, An N, Liang A. Glioma-derived mutations in IDH: from mechanism to potential therapy. Biochem Biophys Res Commun. 2010;397:127-30, doi: 10.1016/j.bbrc.2010.05.115.
-
(2010)
Biochem Biophys Res Commun
, vol.397
, pp. 127-130
-
-
Fu, Y.1
Huang, R.2
Du, J.3
Yang, R.4
An, N.5
Liang, A.6
-
75
-
-
33644552417
-
Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology
-
doi: 10.1073/pnas.0511154103
-
Yu T, Robotham JL, Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci USA. 2006;103:2653-8, doi: 10.1073/pnas.0511154103.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, pp. 2653-2658
-
-
Yu, T.1
Robotham, J.L.2
Yoon, Y.3
-
76
-
-
78751657666
-
The importance of mitochondria in the tumourigenic phenotype: Gliomas as the paradigm (review)
-
Lian BC, Grootveld M. The importance of mitochondria in the tumourigenic phenotype: gliomas as the paradigm (review). Int J Mol Med. 2011;27:159-71.
-
(2011)
Int J Mol Med
, vol.27
, pp. 159-171
-
-
Lian, B.C.1
Grootveld, M.2
-
77
-
-
61449091362
-
Mitochondrial DNA instability and metabolic shift in human cancers
-
doi: 10.3390/ ijms10020674
-
Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009;10:674-701, doi: 10.3390/ ijms10020674.
-
(2009)
Int J Mol Sci
, vol.10
, pp. 674-701
-
-
Lee, H.C.1
Wei, Y.H.2
-
78
-
-
77954218340
-
The role of mitochondria in glioma pathophysiology
-
doi: 10.1007/s12035-010-8133-5
-
Ordys BB, Launay S, Deighton RF, McCulloch J, Whittle IR. The role of mitochondria in glioma pathophysiology. Mol Neurobiol. 2010;42:64-75, doi: 10.1007/s12035-010-8133-5.
-
(2010)
Mol Neurobiol
, vol.42
, pp. 64-75
-
-
Ordys, B.B.1
Launay, S.2
Deighton, R.F.3
McCulloch, J.4
Whittle, I.R.5
-
79
-
-
78650021675
-
Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas
-
doi: 10.1016/j.mito.2010.07.001
-
Correia RL, Oba-Shinjo SM, Uno M, Huang N, Marie SK. Mitochondrial DNA depletion and its correlation with TFAM, TFB1M, TFB2M and POLG in human diffusely infiltrating astrocytomas. Mitochondrion. 2011;11:48-53, doi: 10.1016/j.mito.2010.07.001.
-
(2011)
Mitochondrion
, vol.11
, pp. 48-53
-
-
Correia, R.L.1
Oba-Shinjo, S.M.2
Uno, M.3
Huang, N.4
Marie, S.K.5
-
80
-
-
57649229829
-
Differences in mitochondrial function and antioxidant systems between regions of human glioma
-
doi: 10. 1159/000185559
-
Santandreu FM, Brell M, Gene AH, Guevara R, Oliver J, Couce ME, et al. Differences in mitochondrial function and antioxidant systems between regions of human glioma. Cel Physiol Biochem. 2008;22:757-68, doi: 10. 1159/000185559.
-
(2008)
Cel Physiol Biochem
, vol.22
, pp. 757-768
-
-
Santandreu, F.M.1
Brell, M.2
Gene, A.H.3
Guevara, R.4
Oliver, J.5
Couce, M.E.6
-
81
-
-
8144228566
-
Why do cancers have high aerobic glycolysis?
-
doi: 10.1038/nrc1478
-
Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nature Rev Cancer. 2004;4:891-9, doi: 10.1038/nrc1478.
-
(2004)
Nature Rev Cancer
, vol.4
, pp. 891-899
-
-
Gatenby, R.A.1
Gillies, R.J.2
-
82
-
-
12544256565
-
Inhibition of glycolysis in cancer cells: A novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia
-
doi: 10.1158/0008-5472.CAN-04-4313
-
Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, et al. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res. 2005;65:613-21, doi: 10.1158/0008-5472.CAN-04-4313.
-
(2005)
Cancer Res
, vol.65
, pp. 613-621
-
-
Xu, R.H.1
Pelicano, H.2
Zhou, Y.3
Carew, J.S.4
Feng, L.5
Bhalla, K.N.6
-
83
-
-
1642494855
-
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
-
doi: 10.1158/0008-5472. CAN-03-3294
-
Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, et al. 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res. 2004;64:31-4, doi: 10.1158/0008-5472. CAN-03-3294.
-
(2004)
Cancer Res
, vol.64
, pp. 31-34
-
-
Maschek, G.1
Savaraj, N.2
Priebe, W.3
Braunschweiger, P.4
Hamilton, K.5
Tidmarsh, G.F.6
-
84
-
-
0142058027
-
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide
-
doi: 10.1200/JCO.2003.03.034
-
Papaldo P, Lopez M, Cortesi E, Cammilluzzi E, Antimi M, Terzoli E, et al. Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide. J Clin Oncol. 2003;21:3462-8, doi: 10.1200/JCO.2003.03.034.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3462-3468
-
-
Papaldo, P.1
Lopez, M.2
Cortesi, E.3
Cammilluzzi, E.4
Antimi, M.5
Terzoli, E.6
-
85
-
-
0035123284
-
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
-
doi: 10.1016/S0959-8049(00)00400-7
-
De Lena M, Lorusso V, Latorre A, Fanizza G, Gargano G, Caporusso L, et al. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study. Eur J Cancer. 2001;37:364-8, doi: 10.1016/S0959-8049(00)00400-7.
-
(2001)
Eur J Cancer
, vol.37
, pp. 364-368
-
-
de Lena, M.1
Lorusso, V.2
Latorre, A.3
Fanizza, G.4
Gargano, G.5
Caporusso, L.6
-
86
-
-
0037368877
-
Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors
-
Di Cosimo S, Ferretti G, Papaldo P, Carlini P, Fabi A, Cognetti F. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. Drugs Today (Barc). 2003;39:157-74.
-
(2003)
Drugs Today (Barc)
, vol.39
, pp. 157-174
-
-
di Cosimo, S.1
Ferretti, G.2
Papaldo, P.3
Carlini, P.4
Fabi, A.5
Cognetti, F.6
-
87
-
-
84864371674
-
Metformin and cancer: New applications for an old drug
-
2011 Feb 8. [Epub ahead of print] doi: 10.1007/ S12032-011-9846-7
-
Kourelis TV, Siegel RD. Metformin and cancer: new applications for an old drug. Med Oncol. 2011 Feb 8. [Epub ahead of print] doi: 10.1007/ S12032-011-9846-7.
-
Med Oncol
-
-
Kourelis, T.V.1
Siegel, R.D.2
-
88
-
-
77955923866
-
Metformin: Taking away the candy for cancer?
-
doi: 10.1016/j.ejca.2010.06.012
-
Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, et al. Metformin: taking away the candy for cancer? Eur J Cancer. 2010;46:2369-80, doi: 10.1016/j.ejca.2010.06.012.
-
(2010)
Eur J Cancer
, vol.46
, pp. 2369-2380
-
-
Jalving, M.1
Gietema, J.A.2
Lefrandt, J.D.3
de Jong, S.4
Reyners, A.K.5
Gans, R.O.6
-
89
-
-
20444461067
-
Metformin and reduced risk of cancer in diabetic patients
-
doi: 10.1136/bmj.38415.708634.F7
-
Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304-5, doi: 10.1136/bmj.38415.708634.F7.
-
(2005)
BMJ
, vol.330
, pp. 1304-1305
-
-
Evans, J.M.1
Donnelly, L.A.2
Emslie-Smith, A.M.3
Alessi, D.R.4
Morris, A.D.5
-
90
-
-
55349138793
-
Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets
-
doi: 10.1111/j.1528-1167.2008.01853.x
-
Seyfried TN, Kiebish M, Mukherjee P, Marsh J. Targeting energy metabolism in brain cancer with calorically restricted ketogenic diets. Epilepsia. 2008;49 Suppl 8:114-16, doi: 10.1111/j.1528-1167.2008.01853.x.
-
(2008)
Epilepsia
, vol.49
, Issue.SUPPL. 8
, pp. 114-116
-
-
Seyfried, T.N.1
Kiebish, M.2
Mukherjee, P.3
Marsh, J.4
-
91
-
-
77951233713
-
Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet
-
Seyfried BT, Kiebish M, Marsh J, Mukherjee P. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. J Cancer Res Ther. 2009;5(Suppl 1):S7-15.
-
(2009)
J Cancer Res Ther
, vol.5
, Issue.SUPPL. 1
-
-
Seyfried, B.T.1
Kiebish, M.2
Marsh, J.3
Mukherjee, P.4
-
92
-
-
79958173253
-
Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells
-
2010 May 10. [Epub ahead of print] doi: 10.1016/j.biocel.2010.05.003
-
Smolkova K, Plecitá-Hlavatá L, Bellance N, Bernard G, Rossignol R, Jezek P. Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells. Int J Biochem Cell Biol. 2010 May 10. [Epub ahead of print] doi: 10.1016/j.biocel.2010.05.003.
-
Int J Biochem Cell Biol
-
-
Smolkova, K.1
Plecitá-Hlavatá, L.2
Bellance, N.3
Bernard, G.4
Rossignol, R.5
Jezek, P.6
-
93
-
-
44649135084
-
Gene expression profile analysis of primary glioblas-tomas and non-neoplastic brain tissue: Identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR
-
doi: 10.1007/s11060-008-9579-4
-
Scrideli CA, Carlotti CG Jr, Okamoto OK, Andrade VS, Cortez MA, Motta FJ, et al. Gene expression profile analysis of primary glioblas-tomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol. 2008;88:281-91, doi: 10.1007/s11060-008-9579-4.
-
(2008)
J Neurooncol
, vol.88
, pp. 281-291
-
-
Scrideli, C.A.1
Carlotti Jr., C.G.2
Okamoto, O.K.3
Andrade, V.S.4
Cortez, M.A.5
Motta, F.J.6
-
94
-
-
38349061453
-
Waves of gene regulation suppress and then restore oxidative phosphorylation. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas
-
Marie SK, Okamoto OK, Uno M, Hasegawa AP, Oba-Shinjo SM, Cohen T. Waves of gene regulation suppress and then restore oxidative phosphorylation. Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer. 2008;122:807-15.
-
(2008)
Int J Cancer
, vol.122
, pp. 807-815
-
-
Marie, S.K.1
Okamoto, O.K.2
Uno, M.3
Hasegawa, A.P.4
Oba-Shinjo, S.M.5
Cohen, T.6
-
95
-
-
66249108601
-
Understanding the Warburg effect: The metabolic requirements of cell proliferation
-
doi: 10.1126/science.1160809
-
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029-33, doi: 10.1126/science.1160809.
-
(2009)
Science
, vol.324
, pp. 1029-1033
-
-
van der Heiden, M.G.1
Cantley, L.C.2
Thompson, C.B.3
-
96
-
-
43749092606
-
Epidermal growth factor receptor and glioblastoma multiforme: Molecular basis for a new approach
-
doi: 10.1007/s12094-008-0159-z
-
Belda-Iniesta C, de Castro CJ, Sereno M, Gonza ́lez-Ba ́ron M, Perona R. Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach. Clin Transl Oncol. 2008;10:73-7, doi: 10.1007/s12094-008-0159-z.
-
(2008)
Clin Transl Oncol
, vol.10
, pp. 73-77
-
-
Belda-Iniesta, C.1
de Castro, C.J.2
Sereno, M.3
González-Báron, M.4
Perona, R.5
-
97
-
-
33750596946
-
PIK3CA gene mutations in pediatric and adult glioblastoma multi-forme
-
doi: 10.1158/1541-7786.MCR-06-0172
-
Gallia GL, Rand V, Siu IM, Eberhart CG, James CD, Marie SK, et al. PIK3CA gene mutations in pediatric and adult glioblastoma multi-forme. Mol Cancer Res. 2006;4:709-14, doi: 10.1158/1541-7786.MCR-06-0172.
-
(2006)
Mol Cancer Res
, vol.4
, pp. 709-714
-
-
Gallia, G.L.1
Rand, V.2
Siu, I.M.3
Eberhart, C.G.4
James, C.D.5
Marie, S.K.6
-
98
-
-
34250781164
-
Prognostic significance of co-overexpression of the EGFR/ IGFBP-2/HIF-2A genes in astrocytomas
-
doi: 10.1007/s11060-007-9328-0
-
Scrideli CA, Carlotti CG Jr, Mata JF, Neder L, Machado HR, Oba-Sinjo SM, et al. Prognostic significance of co-overexpression of the EGFR/ IGFBP-2/HIF-2A genes in astrocytomas. J Neurooncol. 2007;83:233-9, doi: 10.1007/s11060-007-9328-0.
-
(2007)
J Neurooncol
, vol.83
, pp. 233-239
-
-
Scrideli, C.A.1
Carlotti Jr., C.G.2
Mata, J.F.3
Neder, L.4
Machado, H.R.5
Oba-Sinjo, S.M.6
-
99
-
-
0033575290
-
Regulation of GLUT1 gene transcription by the serine/threonine kinase akt1
-
doi: 10.1074/jbc.274.29.20281
-
Barthel A, Okino ST, Liao J, Nakatani K, Li J, Whitlock JP Jr, et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase akt1. J Biol Chem. 1999;274:20281-6, doi: 10.1074/jbc.274.29.20281.
-
(1999)
J Biol Chem
, vol.274
, pp. 20281-20286
-
-
Barthel, A.1
Okino, S.T.2
Liao, J.3
Nakatani, K.4
Li, J.5
Whitlock Jr., J.P.6
-
100
-
-
35448964610
-
Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancer's most common phenotypes, the ''Warburg Effect'', i.e., elevated glycolysis in the presence of oxygen
-
doi: 10.1007/ s10863-007-9094-x
-
Pedersen PL. Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancer's most common phenotypes, the ''Warburg Effect'', i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr. 2007;39:211-22, doi: 10.1007/ s10863-007-9094-x.
-
(2007)
J Bioenerg Biomembr
, vol.39
, pp. 211-222
-
-
Pedersen, P.L.1
-
101
-
-
20544449673
-
The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation
-
doi: 10.1038/sj.onc.1208622
-
Buzzai M, Bauer DE, Jones RG, DeBerardinis RJ, Hatzivassiliou G, Elstrom RL, et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene. 2005;16:4165-73, doi: 10.1038/sj.onc.1208622.
-
(2005)
Oncogene
, vol.16
, pp. 4165-4173
-
-
Buzzai, M.1
Bauer, D.E.2
Jones, R.G.3
Deberardinis, R.J.4
Hatzivassiliou, G.5
Elstrom, R.L.6
-
102
-
-
57349194139
-
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
-
doi: 10.1038/nm.1890
-
Engelman JA, Chen L, Tan X, Crosby K, Guimaraes AR, Upadhyay R, et al. Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nature Med. 2008;14:1351-6, doi: 10.1038/nm.1890.
-
(2008)
Nature Med
, vol.14
, pp. 1351-1356
-
-
Engelman, J.A.1
Chen, L.2
Tan, X.3
Crosby, K.4
Guimaraes, A.R.5
Upadhyay, R.6
-
103
-
-
58249119446
-
18F-FDG PET and PET/CT in the evaluation of cancer treatment response
-
doi: 10.2967/ jnumed.108.054205
-
Bem-Haim S, Ell P. 18F-FDG PET and PET/CT in the evaluation of cancer treatment response. J Nucl Med. 2009;50:88-99, doi: 10.2967/ jnumed.108.054205.
-
(2009)
J Nucl Med
, vol.50
, pp. 88-99
-
-
Bem-Haim, S.1
Ell, P.2
-
104
-
-
2542561169
-
Akt stimulates aerobic glycolysis in cancer cells
-
doi: 10.1158/0008-5472.CAN-03-2904
-
Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64:3892-9, doi: 10.1158/0008-5472.CAN-03-2904.
-
(2004)
Cancer Res
, vol.64
, pp. 3892-3899
-
-
Elstrom, R.L.1
Bauer, D.E.2
Buzzai, M.3
Karnauskas, R.4
Harris, M.H.5
Plas, D.R.6
-
105
-
-
0031969042
-
Hypoxia and the regulation of gene expression
-
doi: 10.1016/S1357-4310(97)01198-2
-
Gleadle JM, Ratcliffe PJ. Hypoxia and the regulation of gene expression. Mol Med Today. 1998;4:122-9, doi: 10.1016/S1357-4310(97)01198-2.
-
(1998)
Mol Med Today
, vol.4
, pp. 122-129
-
-
Gleadle, J.M.1
Ratcliffe, P.J.2
-
106
-
-
0028068606
-
Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1
-
Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem. 1994;269:23757-63.
-
(1994)
J Biol Chem
, vol.269
, pp. 23757-23763
-
-
Semenza, G.L.1
Roth, P.H.2
Fang, H.M.3
Wang, G.L.4
-
107
-
-
58149136865
-
Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer
-
doi: 10.1007/s00018-008-8224-x
-
Yeung SJ, Pan J, Lee MH. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cell Mol Life Sci. 2008;65:3981-99, doi: 10.1007/s00018-008-8224-x.
-
(2008)
Cell Mol Life Sci
, vol.65
, pp. 3981-3999
-
-
Yeung, S.J.1
Pan, J.2
Lee, M.H.3
-
108
-
-
54549113030
-
2 sensing and cancer
-
doi: 10.1038/nrc2502
-
Kaelin Jr WG. The von Hippel-Lindau suppressor protein: O2 sensing and cancer. Nature Rev Cancer. 2008;8:865-73, doi: 10.1038/nrc2502.
-
(2008)
Nature Rev Cancer
, vol.8
, pp. 865-873
-
-
Kaelin, W.G.1
-
109
-
-
0030460724
-
Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1
-
doi: 10. 1074/jbc.271.51.32529
-
Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem. 1996;271:32529-37, doi: 10. 1074/jbc.271.51.32529.
-
(1996)
J Biol Chem
, vol.271
, pp. 32529-32537
-
-
Semenza, G.L.1
Jiang, B.H.2
Leung, S.W.3
Passantino, R.4
Concordet, J.P.5
Maire, P.6
-
110
-
-
0037155247
-
Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect
-
Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, et al. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem. 2002;277:6183-7.
-
(2002)
J Biol Chem
, vol.277
, pp. 6183-6187
-
-
Minchenko, A.1
Leshchinsky, I.2
Opentanova, I.3
Sang, N.4
Srinivas, V.5
Armstead, V.6
-
111
-
-
9144236903
-
Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase gene
-
doi: 10. 1093/jb/mvh137
-
Fukasawa M, Tsuchiya T, Takayama E, Shinomiya N, Uyeda K, Sakakibara R, et al. Identification and characterization of the hypoxia-responsive element of the human placental 6-phosphofructo-2-kinase/ fructose-2,6-bisphosphatase gene. J Biochem. 2004;136:273-7, doi: 10. 1093/jb/mvh137.
-
(2004)
J Biochem
, vol.136
, pp. 273-277
-
-
Fukasawa, M.1
Tsuchiya, T.2
Takayama, E.3
Shinomiya, N.4
Uyeda, K.5
Sakakibara, R.6
-
112
-
-
0031875003
-
Expression of hypoxia-inducible genes in tumor cells
-
doi: 10.1007/s004320050175
-
Kress S, Stein A, Maurer P, Weber B, Reichert J, Buchmann A, et al. Expression of hypoxia-inducible genes in tumor cells. J Cancer Res Clin Oncol. 1998;124:315-20, doi: 10.1007/s004320050175.
-
(1998)
J Cancer Res Clin Oncol
, vol.124
, pp. 315-320
-
-
Kress, S.1
Stein, A.2
Maurer, P.3
Weber, B.4
Reichert, J.5
Buchmann, A.6
-
113
-
-
33749478922
-
Cancer's molecular sweet tooth and the Warburg effect
-
doi: 10.1158/0008-5472.CAN-06-1501
-
Kim JW, Dang CV. Cancer's molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66:8927-30, doi: 10.1158/0008-5472.CAN-06-1501.
-
(2006)
Cancer Res
, vol.66
, pp. 8927-8930
-
-
Kim, J.W.1
Dang, C.V.2
-
114
-
-
77955291967
-
The altered metabolism of tumors: HIF-1 and its role in the Warburg effect
-
doi: 10. 1016/j.advenzreg.2009.10.027
-
Stubbs M, Griffiths JR. The altered metabolism of tumors: HIF-1 and its role in the Warburg effect. Adv Enzyme Regul. 2010;50:44-55, doi: 10. 1016/j.advenzreg.2009.10.027.
-
(2010)
Adv Enzyme Regul
, vol.50
, pp. 44-55
-
-
Stubbs, M.1
Griffiths, J.R.2
-
115
-
-
64749116346
-
C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
-
doi: 10.1038/ nature07823
-
Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, et al. C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature. 2009;458:762-5, doi: 10.1038/ nature07823.
-
(2009)
Nature
, vol.458
, pp. 762-765
-
-
Gao, P.1
Tchernyshyov, I.2
Chang, T.C.3
Lee, Y.S.4
Kita, K.5
Ochi, T.6
-
116
-
-
34347402459
-
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
-
doi: 10.1083/jcb. 200703099
-
Yuneva M, Zamboni N, Oefner P, Sachidanandam R, Lazebnik Y. Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol. 2007;178:93-105, doi: 10.1083/jcb. 200703099.
-
(2007)
J Cell Biol
, vol.178
, pp. 93-105
-
-
Yuneva, M.1
Zamboni, N.2
Oefner, P.3
Sachidanandam, R.4
Lazebnik, Y.5
-
117
-
-
57749088701
-
Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
-
doi: 10.1073/pnas.0810199105
-
Wise DR, DeBerardinis RJ, Mancuso A, Sayed N, Zhang XY, Pfeiffer HK, et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA. 2008;105:18782-7, doi: 10.1073/pnas.0810199105.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 18782-18787
-
-
Wise, D.R.1
Deberardinis, R.J.2
Mancuso, A.3
Sayed, N.4
Zhang, X.Y.5
Pfeiffer, H.K.6
-
118
-
-
67650417891
-
c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry
-
doi: 10.1038/onc.2009.112
-
Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery DM. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene. 2009;28:2458-91, doi: 10.1038/onc.2009.112.
-
(2009)
Oncogene
, vol.28
, pp. 2458-2491
-
-
Morrish, F.1
Isern, N.2
Sadilek, M.3
Jeffrey, M.4
Hockenbery, D.M.5
-
119
-
-
0032931517
-
The p53 pathway
-
doi: 10. 1002/(SICI)1096-9896(199901)187:1,112::AID-PATH250.3.0.CO;2-3
-
Prives C, Hall PA. The p53 pathway. J Pathol. 1999;187:112-26, doi: 10. 1002/(SICI)1096-9896(199901)187:1,112::AID-PATH250.3.0.CO;2-3.
-
(1999)
J Pathol
, vol.187
, pp. 112-126
-
-
Prives, C.1
Hall, P.A.2
-
120
-
-
0026669469
-
p53 function and dysfunction
-
doi: 10.1016/0092-8674(92)90421-8
-
Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70:523-6, doi: 10.1016/0092-8674(92)90421-8.
-
(1992)
Cell
, vol.70
, pp. 523-526
-
-
Vogelstein, B.1
Kinzler, K.W.2
-
121
-
-
0029996069
-
Clinical implications of the p53 gene
-
doi: 10.1146/annurev.med.47.1.285
-
Sidransky D, Hollstein M. Clinical implications of the p53 gene. Annu Rev Med. 1996;47:285-301, doi: 10.1146/annurev.med.47.1.285.
-
(1996)
Annu Rev Med
, vol.47
, pp. 285-301
-
-
Sidransky, D.1
Hollstein, M.2
-
122
-
-
0026448672
-
Regulation of the specific DNA binding function of p53
-
doi: 10.1016/0092-8674(92)90562-Q
-
Hupp TR, Meek DW, Midgley C, Lane DP. Regulation of the specific DNA binding function of p53. Cell. 1992;71:875-86, doi: 10.1016/0092-8674(92)90562-Q.
-
(1992)
Cell
, vol.71
, pp. 875-886
-
-
Hupp, T.R.1
Meek, D.W.2
Midgley, C.3
Lane, D.P.4
-
123
-
-
0014587529
-
Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?
-
Li FP, Fraumeni JF Jr. Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann Intern Med. 1969;71:747-52.
-
(1969)
Ann Intern Med
, vol.71
, pp. 747-752
-
-
Li, F.P.1
Fraumeni, J.F.2
-
124
-
-
0025633582
-
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
-
doi: 10.1126/ science.1978757
-
Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science. 1990;250:1233-8, doi: 10.1126/ science.1978757.
-
(1990)
Science
, vol.250
, pp. 1233-1238
-
-
Malkin, D.1
Li, F.P.2
Strong, L.C.3
Fraumeni Jr., J.F.4
Nelson, C.E.5
Kim, D.H.6
-
125
-
-
0027313366
-
A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme
-
doi: 10.1111/j. 1750-3639.1993.tb00749.x
-
Newcomb EW, Madonia WJ, Pisharody S, Lang FF, Koslow M, Miller DC. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol. 1993;3:229-35, doi: 10.1111/j. 1750-3639.1993.tb00749.x.
-
(1993)
Brain Pathol
, vol.3
, pp. 229-235
-
-
Newcomb, E.W.1
Madonia, W.J.2
Pisharody, S.3
Lang, F.F.4
Koslow, M.5
Miller, D.C.6
-
126
-
-
19444367882
-
Detection of somatic TP53 splice site mutations in diffuse astrocytomas
-
doi: 10.1016/j.canlet.2004.10. 022
-
Uno M, Oba-Shinjo SM, de Aguiar PH, Leite CC, Rosemberg S, Miura FK, et al. Detection of somatic TP53 splice site mutations in diffuse astrocytomas. Cancer Lett. 2005;224:321-7, doi: 10.1016/j.canlet.2004.10. 022.
-
(2005)
Cancer Lett
, vol.224
, pp. 321-327
-
-
Uno, M.1
Oba-Shinjo, S.M.2
de Aguiar, P.H.3
Leite, C.C.4
Rosemberg, S.5
Miura, F.K.6
-
127
-
-
34250877865
-
Genetic pathways to primary and secondary glioblastoma
-
doi: 10.2353/ajpath.2007. 070011
-
Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170:1445-53, doi: 10.2353/ajpath.2007. 070011.
-
(2007)
Am J Pathol
, vol.170
, pp. 1445-1453
-
-
Ohgaki, H.1
Kleihues, P.2
-
128
-
-
1942506067
-
The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression
-
doi: 10.1158/ 0008-5472.CAN-03-0846
-
Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 2004;64:2627-33, doi: 10.1158/ 0008-5472.CAN-03-0846.
-
(2004)
Cancer Res
, vol.64
, pp. 2627-2633
-
-
Schwartzenberg-Bar-Yoseph, F.1
Armoni, M.2
Karnieli, E.3
-
129
-
-
43049139541
-
p53 regulates glucose metabolism though an IKK-NF-kappaB pathway and inhibits cell transformation
-
doi: 10.1038/ncb1724
-
Kawauchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism though an IKK-NF-kappaB pathway and inhibits cell transformation. Nature Cell Biol. 2008;10:611-18, doi: 10.1038/ncb1724.
-
(2008)
Nature Cell Biol
, vol.10
, pp. 611-618
-
-
Kawauchi, K.1
Araki, K.2
Tobiume, K.3
Tanaka, N.4
-
130
-
-
11244347171
-
Glycolytic enzymes can modulate cellular lifespan
-
Kondoh H, Lleonart ME, Gil J, Wang J, Degan P, Peters G, et al. Glycolytic enzymes can modulate cellular lifespan. Cancer Res. 2005;65:177-85.
-
(2005)
Cancer Res
, vol.65
, pp. 177-185
-
-
Kondoh, H.1
Lleonart, M.E.2
Gil, J.3
Wang, J.4
Degan, P.5
Peters, G.6
-
131
-
-
33745713432
-
p53 and metabolism: Inside the TIGAR
-
doi: 10.1016/j.cell.2006.06.032
-
Green DR, Chipuk JE. p53 and metabolism: inside the TIGAR. Cell. 2006;126:30-2, doi: 10.1016/j.cell.2006.06.032.
-
(2006)
Cell
, vol.126
, pp. 30-32
-
-
Green D.R.Chipuk, J.E.1
-
132
-
-
59449084996
-
Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator)
-
doi: 10.1074/jbc.M807821200
-
Li H, Jogl G. Structural and biochemical studies of TIGAR (TP53-induced glycolysis and apoptosis regulator). J Biol Chem. 2009; 284:1748-54, doi: 10.1074/jbc.M807821200.
-
(2009)
J Biol Chem
, vol.284
, pp. 1748-1754
-
-
Li, H.1
Jogl, G.2
-
133
-
-
0030882879
-
Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53
-
Mathupala SP, Heese C, Pedersen PL. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem. 1997;272:22776-80.
-
(1997)
J Biol Chem
, vol.272
, pp. 22776-22780
-
-
Mathupala, S.P.1
Heese, C.2
Pedersen, P.L.3
-
134
-
-
67749116522
-
Functions of p53 in metabolism and invasion
-
doi: 10.1042/BST0370511
-
Vousden KH. Functions of p53 in metabolism and invasion. Biochem Soc Trans. 2009;37:511-17, doi: 10.1042/BST0370511.
-
(2009)
Biochem Soc Trans
, vol.37
, pp. 511-517
-
-
Vousden, K.H.1
-
135
-
-
77952192188
-
p53 regulation of metabolic pathways
-
doi: 10.1101/cshperspect. a001040
-
Gottlieb E, Vousden KH. p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol. 2010;2:a001040, doi: 10.1101/cshperspect. a001040.
-
(2010)
Cold Spring Harb Perspect Biol
, vol.2
-
-
Gottlieb, E.1
Vousden, K.H.2
-
136
-
-
33745149291
-
p53 regulates mitochondrial respiration
-
doi: 10.1126/science.1126863
-
Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science. 2006;312:1650-3, doi: 10.1126/science.1126863.
-
(2006)
Science
, vol.312
, pp. 1650-1653
-
-
Matoba, S.1
Kang, J.G.2
Patino, W.D.3
Wragg, A.4
Boehm, M.5
Gavrilova, O.6
-
137
-
-
0033257077
-
Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system
-
Okamura S, Ng CC, Koyama K, Takei Y, Arakawa H, Monden M, et al. Identification of seven genes regulated by wild-type p53 in a colon cancer cell line carrying a well-controlled wild-type p53 expression system. Oncology Res. 1999;11:281-5.
-
(1999)
Oncology Res
, vol.11
, pp. 281-285
-
-
Okamura, S.1
Ng, C.C.2
Koyama, K.3
Takei, Y.4
Arakawa, H.5
Monden, M.6
-
138
-
-
34249811206
-
Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion
-
doi: 10.1038/ng2040
-
Bourdon A, Minai L, Serre V, Jais JP, Sarzi E, Aubert S, et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nature Genet. 2007; 39:776-80, doi: 10.1038/ng2040.
-
(2007)
Nature Genet
, vol.39
, pp. 776-780
-
-
Bourdon, A.1
Minai, L.2
Serre, V.3
Jais, J.P.4
Sarzi, E.5
Aubert, S.6
-
139
-
-
0037716990
-
Mitochondrial impairment in p53-deficient human cancer cells
-
doi: 10.1093/ mutage/18.3.287
-
Zhou S, Kachhap S, Singh KK. Mitochondrial impairment in p53-deficient human cancer cells. Mutagenesis. 2003;18:287-92, doi: 10.1093/ mutage/18.3.287.
-
(2003)
Mutagenesis
, vol.18
, pp. 287-292
-
-
Zhou, S.1
Kachhap, S.2
Singh, K.K.3
-
140
-
-
35448940790
-
A pivotal role for p53: Balancing aerobic respiration and glycolysis
-
doi: 10.1007/s10863-007-9083-0
-
Ma W, Sung HJ, Park JY, Matoba S, Hwang PM. A pivotal role for p53: balancing aerobic respiration and glycolysis. J Bioenerg Biomembr. 2007;39:243-6, doi: 10.1007/s10863-007-9083-0.
-
(2007)
J Bioenerg Biomembr
, vol.39
, pp. 243-246
-
-
Ma, W.1
Sung, H.J.2
Park, J.Y.3
Matoba, S.4
Hwang, P.M.5
-
141
-
-
66249086606
-
p53 regulates mtDNA copy number and mitocheckpoint pathway
-
doi: 10.4103/1477-3163.50893
-
Kulawiec M, Ayyasamy V, Singh KK. p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinogenesis. 2009;8:8, doi: 10.4103/1477-3163.50893.
-
(2009)
J Carcinogenesis
, vol.8
, pp. 8
-
-
Kulawiec, M.1
Ayyasamy, V.2
Singh, K.K.3
-
143
-
-
67349249403
-
The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1
-
doi: 10.1038/ncb1881
-
Herrero-Mendez A, Almeida A, Fernández E, Maestre C, Moncada S, Bolaños JP. The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nature Cell Biol. 2009;11:747-52, doi: 10.1038/ncb1881.
-
(2009)
Nature Cell Biol
, vol.11
, pp. 747-752
-
-
Herrero-Mendez, A.1
Almeida, A.2
Fernández, E.3
Maestre, C.4
Moncada, S.5
Bolaños, J.P.6
-
144
-
-
33644820339
-
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression and resemble stages in neurogenesis
-
doi: 10.1016/j.ccr.2006.02.019
-
Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression and resemble stages in neurogenesis. Cancer Cell. 2006;9:157-73, doi: 10.1016/j.ccr.2006.02.019.
-
(2006)
Cancer Cell
, vol.9
, pp. 157-173
-
-
Phillips, H.S.1
Kharbanda, S.2
Chen, R.3
Forrest, W.F.4
Soriano, R.H.5
Wu, T.D.6
-
145
-
-
42649112047
-
An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors
-
doi: 10.1038/ng.127
-
Bem-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nature Genet. 2008;40:499-507, doi: 10.1038/ng.127.
-
(2008)
Nature Genet
, vol.40
, pp. 499-507
-
-
Bem-Porath, I.1
Thomson, M.W.2
Carey, V.J.3
Ge, R.4
Bell, G.W.5
Regev, A.6
-
146
-
-
34447562894
-
Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes
-
Okamoto OK, Oba-Shinjo SM, Lopes L, Nagahashi Marie SK. Expression of HOXC9 and E2F2 are up-regulated in CD133(+) cells isolated from human astrocytomas and associate with transformation of human astrocytes. Biochim Biophys Acta. 2007;1769:437-42.
-
(2007)
Biochim Biophys Acta
, vol.1769
, pp. 437-442
-
-
Okamoto, O.K.1
Oba-Shinjo, S.M.2
Lopes, L.3
Nagahashi Marie, S.K.4
|